Table 2.
HIV-infected (n=445 CTA/n=599 CT) | HIV-uninfected (n=304 CTA/n=375 CT) | ||||||
---|---|---|---|---|---|---|---|
| |||||||
N | % | OR and 95% CI | N | % | OR and 95% CI | Interaction p-value | |
CAC>0 | |||||||
| |||||||
Low Risk | 178 | 36.0% | 1 (ref) | 117 | 26.5% | 1 (ref) | |
Moderate Risk | 123 | 49.6% | 1.75* [1.10,2.80] | 60 | 36.7% | 1.61 [0.82,3.13] | 0.83 |
High Risk | 298 | 63.8% | 3.13*** [2.13,4.61] | 198 | 71.7% | 7.03*** [4.21,11.76] | 0.01 |
| |||||||
Any Plaque on CCTA | |||||||
| |||||||
Low Risk | 146 | 63.0% | 1 (ref) | 93 | 52.7% | 1 (ref) | |
Moderate Risk | 91 | 76.9% | 1.96* [1.08,3.54] | 52 | 69.2% | 2.02 [0.99,4.13] | 0.95 |
High Risk | 208 | 88.0% | 4.30*** [2.51,7.35] | 159 | 89.3% | 7.50*** [3.93,14.33] | 0.19 |
| |||||||
Non Calcified Plaque Presence | |||||||
| |||||||
Low Risk | 146 | 47.3% | 1 (ref) | 93 | 40.9% | 1 (ref) | |
Moderate Risk | 91 | 61.5% | 1.79* [1.05,3.04] | 52 | 55.8% | 1.82 [0.92,3.62] | 0.96 |
High Risk | 208 | 74.5% | 3.26*** [2.08,5.12] | 159 | 59.1% | 2.09** [1.24,3.52] | 0.21 |
| |||||||
Mixed Plaque Presence | |||||||
| |||||||
Low Risk | 146 | 24.7% | 1 (ref) | 93 | 15.1% | 1 (ref) | |
Moderate Risk | 91 | 36.3% | 1.74 [0.98,3.07] | 52 | 21.2% | 1.51 [0.63,3.63] | 0.80 |
High Risk | 208 | 39.4% | 1.99** [1.25,3.18] | 159 | 45.3% | 4.67*** [2.44,8.93] | 0.04 |
| |||||||
Coronary Stenosis >=50% | |||||||
| |||||||
Low Risk | 146 | 11.6% | 1 (ref) | 93 | 5.4% | 1 (ref) | |
Moderate Risk | 91 | 17.6% | 1.62 [0.77,3.39] | 52 | 7.7% | 1.47 [0.38,5.72] | 0.90 |
High Risk | 208 | 20.2% | 1.92* [1.04,3.53] | 159 | 22.6% | 5.15*** [1.94,13.65] | 0.09 |
Exponentiated coefficients; 95% confidence intervals in brackets
p < 0.05,
p < 0.01,
p < 0.001